Cargando…
Epimedin C Alleviates Glucocorticoid-Induced Suppression of Osteogenic Differentiation by Modulating PI3K/AKT/RUNX2 Signaling Pathway
Secondary osteoporosis is triggered mostly by glucocorticoid (GC) therapy. Dexamethasone (DEX) was reported to inhibit osteogenic differentiation in zebrafish larvae and MC3T3-E1 cells in prior research. In this research, we primarily examined the protective impacts of epimedin C on the osteogenic i...
Autores principales: | Xu, Yongxiang, Chen, Shichun, Huang, Linxuan, Han, Weichao, Shao, Yingying, Chen, Minyi, Zhang, Yusheng, He, Ruirong, Xie, Baocheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291512/ https://www.ncbi.nlm.nih.gov/pubmed/35860032 http://dx.doi.org/10.3389/fphar.2022.894832 |
Ejemplares similares
-
The Impact of Glucagon-Like Peptide 1 Receptor Agonists on Bone Metabolism and Its Possible Mechanisms in Osteoporosis Treatment
por: Xie, Baocheng, et al.
Publicado: (2021) -
Clinical Efficacy and Safety of Human Mesenchymal Stem Cell Therapy for Degenerative Disc Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Xie, Baocheng, et al.
Publicado: (2021) -
Geniposide Alleviates Glucocorticoid-Induced Inhibition of Osteogenic Differentiation in MC3T3-E1 Cells by ERK Pathway
por: Xie, Baocheng, et al.
Publicado: (2019) -
Immunostimulatory activity and structure-activity relationship of epimedin B from Epimedium brevicornu Maxim.
por: Gao, Yuan, et al.
Publicado: (2022) -
Development of epimedin A complex drugs for treating the osteoporosis
por: Liu, Ying, et al.
Publicado: (2021)